Allergy Diagnostics Market: Industry Analysis and Forecast

Introduction

The Global Allergy Diagnostics Market is experiencing strong growth, driven by the increasing prevalence of allergic diseases, growing awareness of early allergy detection, and continuous advancements in diagnostic technologies. The rising adoption of AI-powered diagnostics, molecular allergy testing, point-of-care testing, and at-home diagnostic solutions is transforming allergy diagnosis by improving accuracy, speed, and patient convenience. Furthermore, favorable government reimbursement policies, increasing healthcare investments, and the growing adoption of personalized therapies, including immunotherapy and targeted allergy treatments, are expected to fuel long-term market growth worldwide.

Get Free Sample Of This Premium Report:

https://www.decisionsadvisors.com/request-sample/DAR4493

Allergy Diagnostics Market Insights

Based on Decision Advisors findings, the Global Allergy Diagnostics Market was valued at USD 6.63 Billion in 2024 and is projected to reach USD 18.64 Billion by 2035.

• From 2025 to 2035, the market is expected to grow at a CAGR of 9.85%.

• The market is driven by the increasing incidence of food allergies, respiratory allergies, drug allergies, and skin allergies, coupled with rising awareness regarding early diagnosis and preventive healthcare.

• Growing adoption of AI-enabled diagnostic platforms, molecular diagnostics, and point-of-care testing is improving diagnostic precision and reducing turnaround time.

• Expanding use of personalized medicine, immunotherapy, and targeted allergy treatments, along with favorable reimbursement policies, is further accelerating market growth.

Other Key Findings

• Rising prevalence of allergic disorders worldwide continues to increase demand for advanced diagnostic testing.

• Molecular diagnostics and component-resolved diagnostics are improving the accuracy of allergy identification and personalized treatment planning.

• Increasing availability of home-based allergy testing kits and point-of-care diagnostic solutions is enhancing patient accessibility.

• Government initiatives supporting allergy awareness and reimbursement for diagnostic testing are contributing to market expansion.

• Continuous technological advancements in laboratory automation, AI, and biomarker-based diagnostics are expected to create significant growth opportunities during the forecast period.

Report Summary

Top Companies in Global Allergy Diagnostics Market

• Agnitiost
• bioMérieux
• Danaher Corporation (Beckman Coulter)
• Eurofins Scientific
• EUROIMMUN
• Excelsior Bio-System
• HollisterStier Allergy
• Hycor Biomedical
• Lincoln Diagnostics
• Med Phar Enterprise
• Neogen Corporation
• Omega Diagnostics
• Rega Biotechnology
• SGS Taiwan

Want detailed insights, forecasts, and competitive analysis?

Check out the full report now:
https://www.decisionsadvisors.com/reports/allergy-diagnostics-market